Biologic medicines – from vaccines and insulin to advanced cell and gene therapies – are often temperature-sensitive and require strict cold chain management. In recent years, the rise of biologics has brought new challenges in storing and transporting these fragile products, especially those needing ultra-cold conditions. Looking ahead, cold chain management for biologic drugs is […]
Introduction In the fast-evolving landscape of pharmaceutical manufacturing, Contract Development and Manufacturing Organizations (CDMOs) have become essential partners for drug companies, providing outsourced services from drug development to full-scale production. However, relying solely on CDMOs comes with inherent risks, such as supply chain disruptions, capacity constraints, and quality control issues, which can compromise the timely […]
Introduction As the pharmaceutical landscape faces slowing growth in traditional strongholds, major pharmaceutical companies are turning their focus towards emerging markets. Countries like India, China, and Brazil are witnessing significant investments from Big Pharma, driven by the need to tap into these rapidly growing economies. According to IQVIA data, between 2016 and 2021, the pharmaceutical […]
Executive Summary In recent years, the Contract Development and Manufacturing Organization (CDMO) industry has experienced substantial growth, particularly in the United States, driven by the increasing complexity of drug development and the need for cost-efficient, scalable manufacturing solutions. As pharmaceutical companies focus on their core competencies, outsourcing production to CDMOs has become a strategic imperative. […]
Introduction The Contract Development and Manufacturing Organization (CDMO) sector has become a critical player in the U.S. pharmaceutical industry, particularly as companies increasingly outsource drug development and manufacturing to focus on core competencies. With the rise of advanced therapeutics, such as cell and gene therapies, and the ongoing pressures of a post-pandemic market, CDMOs face […]
The pharmaceutical industry has long been a beacon of innovation, with research and development (R&D) at its core. However, recent trends indicate a significant shift in how major pharmaceutical companies are approaching their R&D investments. The ramifications of these changes may change the future of drug discovery and development. The Current Landscape The COVID-19 pandemic […]
The life sciences industry is being shaped by technological advancements, regulatory changes, and evolving market conditions. Here are the top-5 factors influencing the sector: 1. Finding Capital Investment Securing capital remains a critical challenge for life sciences companies, especially startups and early-stage ventures, due to market volatility and regulatory uncertainties. Despite this, there is still […]
At Euro-American, we take pride in maintaining optimal conditions for our pharmaceutical clients, ensuring their products remain safe and effective. In August 2023, we conducted a comprehensive validation study for our newly completed 20,000 sq. ft. expansion. The results were remarkable, solidifying our commitment to excellence in warehouse temperature control. Our state-of-the-art facility successfully maintained […]
The Culprit: Single-Use Materials For CDMOs (Contract Development and Manufacturing Organizations), growth is both exciting and challenging. New clients and additional batch runs for existing clients often result in an immediate influx of single-use raw materials. This sudden increase of on-hand inventory can quickly overwhelm existing warehouse space, driving the need for additional warehouse space. […]
While 2023 might seem less tumultuous compared to the pandemic years, it was far from uneventful. Technological advancements, the rise of artificial intelligence, and volatile global relations shaped the year. Nearshoring and reshoring became critical, and a low unemployment rate made hiring and retaining logistics talent challenging. Inflation, rising interest rates, and the threat of […]